vs

Side-by-side financial comparison of Exodus Movement, Inc. (EXOD) and PETMED EXPRESS INC (PETS). Click either name above to swap in a different company.

PETMED EXPRESS INC is the larger business by last-quarter revenue ($40.7M vs $29.4M, roughly 1.4× Exodus Movement, Inc.). PETMED EXPRESS INC runs the higher net margin — -26.0% vs -181.0%, a 155.0% gap on every dollar of revenue. On growth, PETMED EXPRESS INC posted the faster year-over-year revenue change (-23.3% vs -34.4%). PETMED EXPRESS INC produced more free cash flow last quarter ($-9.2M vs $-25.8M). Over the past eight quarters, Exodus Movement, Inc.'s revenue compounded faster (0.6% CAGR vs -20.9%).

Exodus is a cryptocurrency wallet available on desktop and mobile platforms. It was founded in 2015 by JP Richardson and Daniel Castagnoli. Exodus wallet supports digital assets including Bitcoin, Ethereum, and Solana. It is available on Windows, macOS, Linux, iOS, Android, and as a browser extension.

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

EXOD vs PETS — Head-to-Head

Bigger by revenue
PETS
PETS
1.4× larger
PETS
$40.7M
$29.4M
EXOD
Growing faster (revenue YoY)
PETS
PETS
+11.1% gap
PETS
-23.3%
-34.4%
EXOD
Higher net margin
PETS
PETS
155.0% more per $
PETS
-26.0%
-181.0%
EXOD
More free cash flow
PETS
PETS
$16.6M more FCF
PETS
$-9.2M
$-25.8M
EXOD
Faster 2-yr revenue CAGR
EXOD
EXOD
Annualised
EXOD
0.6%
-20.9%
PETS

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
EXOD
EXOD
PETS
PETS
Revenue
$29.4M
$40.7M
Net Profit
$-53.2M
$-10.6M
Gross Margin
23.3%
Operating Margin
-226.9%
-25.7%
Net Margin
-181.0%
-26.0%
Revenue YoY
-34.4%
-23.3%
Net Profit YoY
-179.5%
-1392.6%
EPS (diluted)
$-0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EXOD
EXOD
PETS
PETS
Q4 25
$29.4M
$40.7M
Q3 25
$30.3M
$44.4M
Q2 25
$25.8M
$51.2M
Q1 25
$36.0M
$50.8M
Q4 24
$44.8M
$52.0M
Q3 24
$20.1M
$58.0M
Q2 24
$22.3M
$66.2M
Q1 24
$29.1M
$65.1M
Net Profit
EXOD
EXOD
PETS
PETS
Q4 25
$-53.2M
$-10.6M
Q3 25
$17.0M
$-8.5M
Q2 25
$37.7M
$-34.2M
Q1 25
$-12.9M
$-11.6M
Q4 24
$66.9M
$-707.0K
Q3 24
$843.0K
$2.3M
Q2 24
$-9.6M
$3.8M
Q1 24
$54.8M
$-5.0M
Gross Margin
EXOD
EXOD
PETS
PETS
Q4 25
23.3%
Q3 25
28.0%
Q2 25
28.1%
Q1 25
29.9%
Q4 24
31.0%
Q3 24
43.7%
32.3%
Q2 24
51.7%
28.8%
Q1 24
63.2%
29.3%
Operating Margin
EXOD
EXOD
PETS
PETS
Q4 25
-226.9%
-25.7%
Q3 25
66.9%
-18.9%
Q2 25
-66.7%
Q1 25
-60.4%
-11.9%
Q4 24
-0.9%
Q3 24
-0.3%
1.0%
Q2 24
-66.1%
6.6%
Q1 24
-5.9%
Net Margin
EXOD
EXOD
PETS
PETS
Q4 25
-181.0%
-26.0%
Q3 25
56.2%
-19.2%
Q2 25
145.8%
-66.7%
Q1 25
-35.8%
-22.9%
Q4 24
149.4%
-1.4%
Q3 24
4.2%
4.0%
Q2 24
-43.1%
5.7%
Q1 24
188.5%
-7.7%
EPS (diluted)
EXOD
EXOD
PETS
PETS
Q4 25
$-0.50
Q3 25
$-0.41
Q2 25
$-1.65
Q1 25
$-0.56
Q4 24
$-0.03
Q3 24
$0.11
Q2 24
$0.18
Q1 24
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EXOD
EXOD
PETS
PETS
Cash + ST InvestmentsLiquidity on hand
$4.9M
$26.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$247.4M
$32.8M
Total Assets
$266.8M
$88.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EXOD
EXOD
PETS
PETS
Q4 25
$4.9M
$26.9M
Q3 25
$50.5M
$36.1M
Q2 25
$52.9M
$41.1M
Q1 25
$59.8M
$54.7M
Q4 24
$37.9M
$50.1M
Q3 24
$26.5M
$52.0M
Q2 24
$27.8M
$46.0M
Q1 24
$21.0M
$55.3M
Stockholders' Equity
EXOD
EXOD
PETS
PETS
Q4 25
$247.4M
$32.8M
Q3 25
$296.7M
$43.1M
Q2 25
$277.1M
$51.5M
Q1 25
$241.5M
$85.1M
Q4 24
$257.5M
$96.2M
Q3 24
$191.2M
$96.4M
Q2 24
$190.8M
$93.5M
Q1 24
$199.1M
$96.7M
Total Assets
EXOD
EXOD
PETS
PETS
Q4 25
$266.8M
$88.0M
Q3 25
$338.5M
$100.3M
Q2 25
$313.7M
$109.8M
Q1 25
$263.2M
$148.7M
Q4 24
$288.0M
$144.8M
Q3 24
$211.6M
$146.0M
Q2 24
$211.6M
$152.7M
Q1 24
$225.4M
$169.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EXOD
EXOD
PETS
PETS
Operating Cash FlowLast quarter
$-25.6M
$-9.2M
Free Cash FlowOCF − Capex
$-25.8M
$-9.2M
FCF MarginFCF / Revenue
-87.9%
-22.7%
Capex IntensityCapex / Revenue
0.9%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-42.3M
$-23.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EXOD
EXOD
PETS
PETS
Q4 25
$-25.6M
$-9.2M
Q3 25
$-4.8M
$-2.2M
Q2 25
$-5.3M
$-12.3M
Q1 25
$-6.2M
$7.0M
Q4 24
$-12.0M
$-1.2M
Q3 24
$-4.9M
$7.4M
Q2 24
$-2.4M
$-8.5M
Q1 24
$450.0K
$7.1M
Free Cash Flow
EXOD
EXOD
PETS
PETS
Q4 25
$-25.8M
$-9.2M
Q3 25
$-4.8M
$-4.8M
Q2 25
$-5.4M
$-13.6M
Q1 25
$-6.2M
$4.6M
Q4 24
$-12.3M
$-1.9M
Q3 24
$-4.9M
$6.1M
Q2 24
$-2.4M
$-9.2M
Q1 24
$300.0K
$5.9M
FCF Margin
EXOD
EXOD
PETS
PETS
Q4 25
-87.9%
-22.7%
Q3 25
-16.0%
-10.8%
Q2 25
-20.7%
-26.5%
Q1 25
-17.3%
9.1%
Q4 24
-27.5%
-3.7%
Q3 24
-24.5%
10.6%
Q2 24
-10.8%
-13.9%
Q1 24
1.0%
9.0%
Capex Intensity
EXOD
EXOD
PETS
PETS
Q4 25
0.9%
0.1%
Q3 25
0.1%
5.9%
Q2 25
0.4%
2.5%
Q1 25
0.1%
4.7%
Q4 24
0.6%
1.5%
Q3 24
0.2%
2.2%
Q2 24
0.2%
1.0%
Q1 24
0.5%
1.9%
Cash Conversion
EXOD
EXOD
PETS
PETS
Q4 25
Q3 25
-0.28×
Q2 25
-0.14×
Q1 25
Q4 24
-0.18×
Q3 24
-5.80×
3.18×
Q2 24
-2.27×
Q1 24
0.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EXOD
EXOD

Exchange Aggregation$26.6M90%
Other$2.8M10%

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

Related Comparisons